TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,646,000 | +128.4% | 48,452 | -18.5% | 0.99% | +138.9% |
| Q1 2022 | $1,596,000 | -28.0% | 59,452 | +28.0% | 0.42% | -25.3% |
| Q4 2021 | $2,216,000 | -20.5% | 46,452 | +10.7% | 0.56% | -24.6% |
| Q3 2021 | $2,787,000 | -25.3% | 41,952 | -12.3% | 0.74% | -5.4% |
| Q2 2021 | $3,733,000 | +275.6% | 47,852 | +355.3% | 0.78% | +230.9% |
| Q1 2021 | $994,000 | -33.7% | 10,509 | -54.7% | 0.24% | -45.5% |
| Q2 2020 | $1,499,000 | -28.4% | 23,210 | -50.5% | 0.43% | -50.5% |
| Q1 2020 | $2,095,000 | +10.6% | 46,908 | +54.3% | 0.87% | +34.5% |
| Q4 2019 | $1,894,000 | +6.5% | 30,408 | -35.7% | 0.65% | -2.8% |
| Q3 2019 | $1,779,000 | – | 47,308 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |